Clinical Trial Update: Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating recombinant human endostatin delivered via an adenovirus in combination with chemotherapy for advanced…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Recombinant human endostatin adenovirus (recombinant human endostatin adenovirus)

Snippet

Sponsor: Renmiao Zhang | Conditions: Head and Neck Neoplasms | Phase 2 | Status: UNKNOWN